China SXT Pharmaceuticals SXTC Income Statement (2023-2026)

NASDAQ SXTC
$0.07 -0.04 (-39.75%)
As of: Oct 20, 2026 · 3:59 PM EDT
Reported Financials

China SXT Pharmaceuticals Quarterly Income Statement

Periods 6 quarters
Latest Mar 2026

China SXT Pharmaceuticals income statement data for the quarter ended Mar 2026. This income statement covers 6 quarters of results from Sep 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Additional items
Shares Outstanding 0.00M0.00M0.00M0.00M0.00M0.01M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.01M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.01M0.01M

China SXT Pharmaceuticals Income Statement API

Pull China SXT Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SXTC&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY